Laurie J. Hall Trustee’s AbbVie ABBV Stock Holding History

Laurie J. Hall Trustee’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.45M	Hold	13,705	–	–	1.07%	30
2026 Q1	$2.98M	Sell	13,705 -790	-5%	-$175K	1.05%	32
2025 Q4	$3.31M	Hold	14,495	–	–	1.1%	31
2025 Q3	$3.36M	Hold	14,495	–	–	1.1%	29
2025 Q2	$2.69M	Sell	14,495 -400	-3%	-$74.3K	0.89%	36
2025 Q1	$3.12M	Sell	14,895 -615	-4%	-$120K	1.11%	31
2024 Q4	$2.76M	Sell	15,510 -160	-1%	-$29.4K	0.9%	33
2024 Q3	$3.09M	Hold	15,670	–	–	0.98%	31
2024 Q2	$2.69M	Sell	15,670 -60	-0.4%	-$9.94K	0.94%	33
2024 Q1	$2.86M	Sell	15,730 -2,770	-15%	-$477K	1.01%	33
2023 Q4	$2.87M	Hold	18,500	–	–	1.1%	32
2023 Q3	$2.76M	Sell	18,500 -165	-0.9%	-$24.2K	1.17%	33
2023 Q2	$2.52M	Sell	18,665 -125	-0.7%	-$18.3K	1%	36
2023 Q1	$3M	Hold	18,790	–	–	1.28%	29
2022 Q4	$3.04M	Sell	18,790 -300	-2%	-$46K	1.37%	27
2022 Q3	$2.56M	Hold	19,090	–	–	1.26%	26
2022 Q2	$2.92M	Sell	19,090 -185	-1%	-$28.3K	1.37%	26
2022 Q1	$3.13M	Sell	19,275 -300	-2%	-$43.6K	1.2%	25
2021 Q4	$2.65M	Hold	19,575	–	–	0.94%	33
2021 Q3	$2.11M	Sell	19,575 -1,050	-5%	-$120K	0.82%	42
2021 Q2	$2.32M	Sell	20,625 -100	-0.5%	-$11.3K	0.88%	39
2021 Q1	$2.24M	Sell	20,725 -620	-3%	-$66.3K	0.86%	43
2020 Q4	$2.29M	Sell	21,345 -225	-1%	-$21.6K	0.93%	41
2020 Q3	$1.89M	Buy	+21,570	New	+$2.03M	0.85%	42
2019 Q4	$2.05M	Sell	23,128 -633	-3%	-$52.6K	0.95%	36
2019 Q3	$1.8M	Sell	23,761 -3,325	-12%	-$228K	0.92%	35
2019 Q2	$1.97M	Sell	27,086 -15,221	-36%	-$1.2M	1.02%	32
2019 Q1	$3.41M	Sell	42,307 -1,400	-3%	-$115K	1.8%	14
2018 Q4	$3.49M	Sell	43,707 -4,608	-10%	-$405K	1.93%	14
2018 Q3	$4.57M	Sell	48,315 -250	-0.5%	-$23.7K	2.41%	12
2018 Q2	$4.5M	Sell	48,565 -1,950	-4%	-$190K	2.59%	11
2018 Q1	$4.78M	Sell	50,515 -1,530	-3%	-$168K	2.91%	8
2017 Q4	$5.03M	Sell	52,045 -140	-0.3%	-$13.2K	2.87%	10
2017 Q3	$4.64M	Sell	52,185 -10	-0%	-$761	2.89%	11
2017 Q2	$3.78M	Sell	52,195 -250	-0.5%	-$16.8K	2.42%	11
2017 Q1	$3.41M	Sell	52,445 -350	-0.7%	-$22K	2.17%	11
2016 Q4	$3.37M	Buy	+52,795	New	+$3.22M	2.15%	11
2016 Q2	$3.68M	Sell	57,143 -1,678	-3%	-$102K	2.4%	11
2016 Q1	$3.61M	Sell	58,821 -2,620	-4%	-$146K	2.28%	13
2015 Q4	$3.29M	Sell	61,441 -1,220	-2%	-$70.3K	2.37%	12
2015 Q3	$3.41M	Sell	62,661 -300	-0.5%	-$19.5K	2.72%	12
2015 Q2	$4.23M	Hold	62,961	–	–	3.08%	10
2015 Q1	$3.69M	Hold	62,961	–	–	2.69%	11
2014 Q4	$4.12M	Sell	62,961 -750	-1%	-$47.3K	2.94%	10
2014 Q3	$3.68M	Hold	63,711	–	–	2.77%	10
2014 Q2	$3.6M	Sell	63,711 -100	-0.2%	-$5.25K	2.7%	10
2014 Q1	$3.28M	Sell	63,811 -200	-0.3%	-$10.1K	2.54%	10
2013 Q4	$3.38M	Hold	64,011	–	–	2.6%	10
2013 Q3	$2.86M	Hold	64,011	–	–	2.41%	11
2013 Q2	$2.65M	Buy	+64,011	New	+$2.8M	2.34%	11

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Laurie J. Hall Trustee's ABBV Position: Q2 2026 in Review

Laurie J. Hall Trustee held its AbbVie (ABBV) position steady in Q2 2026 at 13,705 shares worth $3.45M. The position accounts for 1.07% of the portfolio, ranked #30.

Laurie J. Hall Trustee first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.03M in Q4 2017. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Laurie J. Hall Trustee held 13,705 shares of AbbVie worth $3.45M as of Q2 2026.
Laurie J. Hall Trustee left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.07% of Laurie J. Hall Trustee's portfolio in Q2 2026, its #30 holding.
Laurie J. Hall Trustee first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
Laurie J. Hall Trustee's AbbVie position peaked at $5.03M in Q4 2017.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2026, filed 9 Jul 2026.